
Keywords: urinary bladder; neurogenic; Parkinson disease; mesenchymal stromal cells; urodynamics; substantia nigra6-OHDA, 6-hydroxydopamine; BC, bladder capacity; BMSC, bone marrow derived mesenchymal stromal cell; BP, basal pressure; EGFP, enhanced GFP; ErBMSC, mi